Tubular PAH transport capacity in human kidney tissue and in renal cell carcinona: Correlation with various clinical and morphological parameters of the tumor

Urological Research

Volumn 25, Issue 3, 1997, Pages 167-171

  Fleck, C ^a   Gockeritz S ^a   Schubert, J ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Human; p Aminohippurate; Rat; Renal cell carcinoma; Renal cortical slices; Renal tubular transport

Indexed keywords

4 AMINOHIPPURIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; KIDNEY CARCINOMA; KIDNEY TUBULE FUNCTION; PRIORITY JOURNAL;

AGED; ANIMALS; BIOLOGICAL TRANSPORT; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY CORTEX; KIDNEY FUNCTION TESTS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; P-AMINOHIPPURIC ACID; RATS; RATS, WISTAR;

EID: 0030981071     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00941977     Document Type: Article

References (30)

1. Berlion M, Arvelo F, Leonce S, Bourgeois Y, Rigaudy P, Bizzari JP. Poupon MF (1993) Antitumor activity of the new vinca-alkaloid S 12363 alone or in combination with verapamil on a human multidrug resistant renal carcinoma xenograft. In Vivo 7:399-405
2. Bratton AC, Marshall EK (1939) A new coupling component for sulfonamide determination. J Biol Chem 128:537-550
3. Bräunlich H (1981) Excretion of drugs during postnatal development. Pharmacol Ther 12:299-320
4. Bräunlich H, Pils W (1992) Synergistic effect of triiodothyronine and dexamethasone on renal tubular transport of p-aminohippurate in rats of different ages. Dev Pharmacol Ther 19:50-56
5. Bräunlich H, Meinig T, Grosch U (1993) Postnatal development of sex differences in renal tubular transport of p-aminohippurate (PAH) in rats. Exp Toxicol Pathol 45:309-313
6. Broxterman HJ, Pinedo HM, Kuiper CM, van der Hoeven JJ, de Lange P, Quak JJ, Scheper RJ, Keizer HG, Schuurhuis GJ, Lankelma J (1989) Immunohistochemical detection of P-glycoprotein in human tumor cells with a low degree of drug resistance. Int J Cancer 43:340-343
7. Chapman AE, Goldstein LJ (1995) Multiple drug resistance: Biologic basis and clinical significance in renal-cell carcinoma. Semin Oncol 22:17-28
8. Efferth T, Lohrke H, Volm M (1989) Reciprocal correlation between expression of P-glycoprotein and accumulation of rhodamine 123 in human tumors. Anticancer Res 9:1633-1637
9. Eliason JF, Ramuz H, Yoshikubo T, Ishikawa T, Yamamoto T, Tsuruo T (1995) Novel dithiane analogues of tiapamil with high activity to overcome multidrug resistance in vitro. Biochem Pharmacol 50:187-196
10. Fisher RL, Sanuik JT, Gandolfi AJ, Brendel K (1994) Toxicity of cisplatin and mercuric chloride in human kidney cortical slices. Hum Exp Toxicol 13:517-523
11. Fleck C, Kunze C, Bräunlich H (1987) Relation between renal and hepatic excretion of drugs: V. Factors influencing accumulation of phenol red in kidney and liver tissue from rats of different ages. Exp Pathol 32:99-110
12. Fleck C, Haubold D, Hillmann T, Mockel H, Möckel M, Bräunlich H (1993) Evaluation of methods indicating higher susceptibility of immature rats to renal ischemia. Exp Toxicol Pathol 45:155-160
13. Focan C (1995) Circadian rhythms and cancer chemotherapy. Pharmacol Ther 67:1-52
14. Gottesman MM, Hrycyna CA, Schoenlein PV, German UA, Pastan I (1995) Genetic analysis of the multidrug transporter. Ann Rev Genetics 29:607-649
15. Hermanek P, Schrott KM (1990) Evaluation of the new tumor, nodes and metastases classification of renal cell carcinoma. J Urol 144:238-242
16. Klinger W, Muller D, Kleeberg U, Barth A (1983) Extrapolation von Tierversuchen auf Reaktionen beim Menschen. Pharmazie 38:621-623
17. Lai T, Collins CM, Hall P, Morgan AP, Smith PJ, Stonebridge BR, Symes MO (1993) Verapamil enhances doxorubicin activity in cultured human renal carcinoma cells. Eur J Cancer 29A:378-383
18. Licht T, Gottesman, MM, Pastan I (1995) Transfer of the MDR I (multidrug resistance) gene. Protection of hematopoietic cells from cytotoxic chemotherapy, and selection of transduced cells in vivo. Cytokin Mol Ther 1:11-20
19. Mickisch GH (1994a) Therapie des Nierenzellkarzinoins - Eine Aktualisierung notwendig? Akta Urol 25:77-83
20. Mickisch GH (1994b) Multidrug Resistance des Nierenzellkarzinoms - Von der Laborkuriosität zur klinischen Realität. Akta Urol 25:327-337
21. Mickisch GH, Merlino GT, Aiken PM, Gottesman MM, Pastan I (1991) New potent verapamil derivatives that reverse multidrug resistance in human renal carcinoma cells and in transgenic mice expressing the human MDR1 gene. J Urol 146:447-453
22. Naito S, Sakamoto N, Kotoh S, Goto K, Matsumoto T, Kumazawa J (1993) Expression of P-glycoprotein and multidrug resistance in renal cell carcinoma. Eur Urol 24:156-160
23. Nishiyama K, Shirahama T, Yoshimura A, Sumizawa T, Furukawa T, Ichikawa-Haraguchi M, Akiyama S, Ohi Y (1993) Expression of the multidrug transporter, P-glycoprotein, in renal and transitional cell carcinomas. Cancer 71:3611-3619
24. Okada S, Hamazaki S, Ebina Y, Li JL, Midorikawa O (1987) Nephrotoxicity and its prevention by vitamin E in ferric nitrilotriacetate-promoted lipid peroxidation. Biochim Biophys Acta 922:28-33
25. Palmer BF. Levi M (1996) Effect of aging on renal function and disease. In. Brenner BM (ed) The kidney, 5th edn. WB Saunders, Philadelphia, pp 2274-2298
26. Robsen CJ, Churchill BM, Anderson W (1969) The results of radical nephrectomy for renal cell carcinoma J Urol 101:297-301
27. Skinner DG, Calvin RB, Vermillion CD, Pfister RC, Leadbetter WF (1971) Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer 28:1165-1177
28. Stopp M, Bräunlich H (1975) Die Akkumulation von p-Aminohippursäure und Zyklopenthiazid in Nierenrindenschnitten verschieden alter Ratten und ihre Abhängigkeit von der Energiebereitstellung. Acta Biol Med Germ 34:89-98
29. Stopp M, Bräunlich H (1980) In vitro analysis of drug-induced stimulation of renal tubular p-aminohippurate (PAH) transport in rats. Biochem Pharmacol 29:983-986
30. Volm M, Pommerenke EW, Efferth T, Lohrke H, Mattern J (1991) Circumvention of multi-drug resistance in human kidney and kidney carcinoma in vitro. Cancer 67:2484-2489